No votes yet

Renal Cell Carcinoma

Laura S. Wood
CJON 2009, 13(6), 3-7 DOI: 10.1188/09.CJON.S2.3-7

Kidney cancer is most often diagnosed incidentally at the time of radiographic imaging for other complaints. Although numerous improvements and greater use of screening measures have occurred in the setting of renal cell carcinoma (RCC), screening for this disease is usually only carried out for patients who have been identified as having one of the known genetic lineages linked with specific RCC subtypes. This article reviews key concepts in the screening, diagnosis, and prognosis of patients with RCC.


American Cancer Society. (2007). Kidney cancer: How is kidney cancer staged? Survival rates for kidney cancer by TNM stage. Retrieved January 2, 2009, from <a target="_blank" href='http://www.cancer.org/docroot/CRI/content/CRI_2_4_3X_How_is_kidney_cance...

Ascenti, G., Gaeta, M., Magno, C., Mazziotti, S., Blandino, A., Melloni, D., et al. (2004). Contrast-enhanced second-harmonic sonography in the detection of pseudocapsule in renal cell carcinoma. <i>American Journal of Roentgenology</i>, 182(6), 1525-1530.

Bechtold, R.E., & Zagoria, R.J. (1997). Imaging approach to staging of renal cell carcinoma. <i>Uroradiology</i>, 23(3), 507-522.

Campbell, S.C., Novick, A.C., & Bukowski, R.M. (2006). Renal tumors. In A.J. Wein, L.R. Kavoussi, A.C. Novick, A.W. Partin, & C.A. Peters (Eds.), <i>Campbell-Walsh urology</i> (9th ed., pp. 1567-1637). Philadelphia: Elsevier.

Canda, A.E., & Kirkali, Z. (2006). Management of renal cell carcinoma and targeted therapy. <i>Urology Journal</i>, 3(1), 1-14.

Chin, A.I., Lam, J.S., Figlin, R.A., & Belldegrun, A.S. (2006). Surveillance strategies for renal cell carcinoma patients following nephrectomy. <i>Reviews in Urology</i>, 8(1), 1-7.

Cohen, H.T., & McGovern, F.J. (2005). Renal-cell carcinoma. <i>New England Journal of Medicine</i>, 353(23), 2477-2490.

Curry, N.S., Francis, I.R., Baumgarten, D.A., Bluth, E.I., Bush, W.J., Jr., Casalino, D.D., et al. (2007). Renal cell carcinoma staging. <i>ACR Appropriateness Review</i>, 1-8.

Escudier, B., Eisen, T., Stadler, W.M., Szczlik, C., Oudard, S., Siebels, M., et al. (2007). Sorafenib in advanced clear cell renal cell carcinoma. <i>New England Journal of Medicine</i>, 356(2), 125-134.

Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M.J. (2009). Cancer statistics, 2009. <i>CA: A Cancer Journal for Clinicians</i>, 59(4), 225-249.

Lawrentschuk, N., Gani, J., Riordan, R., Esler, S., & Bolton, D.M. (2005). Multidetector computed tomography vs. magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: A study and review. <i>BJU International</i> 96(3), 291-295.

Martignoni, G., Brunelli, M., Gobbo, S., Remo, A., Ficarra, V., Cossu-Rocca, P., et al. (2007). Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. <i>Analytical and Quantitative Cytology and Histology</i>, 29(1), 41-49.

McDonald, M.M., Swagerty, D., & Wetzel, L. (2006). Assessment of microscopic hematuria in adults. <i>American Family Physician</i>, 73(10), 1748-1754.

McLennan, B.L. (2006). Oncologic imaging. Staging and follow-up of renal and adrenal carcinoma. <i>Cancer</i>, 67(4), 1199-1208.

Moldawer, N.P., & Figlin, R. (2008). Renal cell carcinoma: The transition of molecular biology into new treatments, new patient outcomes, and nursing implications. <i>Oncology Nursing Forum</i>, 35(4), 699-708.

Motzer, R.J., Bander, N.H., & Nanus, D.M. (1996). Renal cell carcinoma. <i>New England Journal of Medicine</i>, 335(12), 865-875.

National Comprehensive Cancer Network. (2009). <i>NCCN Clinical Practice Guidelines in Oncology™: Kidney cancer</i> [v.1.09]. Retrieved December 23, 2008, from <a target="_blank" href='http://www.nccn.org/professional/physician_gls/f_guidelines.asp'>http://...

Nelson, E.C., Evans, C.P., & Lara, P.N., Jr. (2007). Renal cell carcinoma: Current status and emerging therapies. <i>Cancer Treatment Reviews</i>, 33(3), 299-313.

Park, J.W., Jo, M.K., & Lee, H.M. (2009). Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. <i>BJU International</i>, 103(5), 615-619.

Renshaw, A.A., Lee, K.R., Madge, R., & Granter, S.R. (1997). Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. <i>Acta Cytologica</i>, 41(4), 987-994.

Rezneck, R.H. (2004). CT/MRI in staging renal cell carcinoma. <i>Cancer Imaging</i>, 4(4, Spec No. A), S25-S32.

Rodriguez-Jasso, V.H., Serrano-Brambila, E., & Maldonado-Alcaraz, E. (2008). Prognostic factors in localized and locally advanced renal cancer. <i>Actas Urologicas Espanolas</i>, 32(3), 320-323.

Schrader, A.J., Rauer-Bruening, S., Olbert, P.J., Hegele, A., Rustemeier, J., Timmesfeld, N., et al. (2009). Incidence and long-term prognosis of papillary renal cell carcinoma. <i>Journal of Cancer Research and Clinical Oncology</i>, 135(6), 799-805.

Shirkhoda, A. (2005). Imaging of cystic and solid renal mass and the role of MRI. <i>Iran Journal of Radiology</i>, 3(1), 1-6.

Shvarts, O., Han, K.R., Seltzer, M., Pantuck, A.J., & Belldegrun, A.S. (2002). Positron emission tomography in urologic oncology. <i>Cancer Control</i>, 9(4), 335-342.

Siow, W.Y., Yip, S.K.H., Ng, L.G., Tan, P.H., Cheng, W.S., & Foo, K.T. (2000). Renal cell carcinoma: Incidental detection and pathological staging. <i>Journal of the Royal College of Surgeons of Edinburgh</i>, 45(5), 291-295.

Volpe, A., Panzarella, T., Rendon, R.A., Haider, M.A., Kondylis, F.I., & Jewett, M.A. (2003). The natural history of incidentally detected small renal masses. <i>Cancer</i>, 100(4), 738-745.

Yang, C.Y., Tiu, C.M., Chou, Y.H., Wang, H.K., Chiou, H.J., Wang, J.H., et al. (2007). Sonographic appearances of renal cell carcinoma: A review of 78 patients. <i>Chinese Journal of Radiology</i>, 32, 177-183.

Zwiezig, S.L. (2002). Cancer of the kidney. <i>Clinical Obstetrics and Gynecology</i>, 45(3), 884-891.